Back
Hims & Hers Shares Fall 4.5% Despite Grail Cancer Test Deal
Back
Stock News
Themes
Hims & Hers Shares Fall 4.5% Despite Grail Cancer Test Deal
Hims & Hers Shares Fall 4.5% Despite Grail Cancer Test Deal
Edgen Stock
·
Feb 04 2026, 22:35
Share to
Share to
Copy link
HIMS
-2.03%
GRAL
+3.28%
source:
[1] Hims & Hers Scores A Cancer Deal With Grail, But Shares Reverse Lower
Recommend
Celanese Q4 Earnings Plunge 54%, Missing Estimates
Feb 17 2026, 23:34
RB Global Beats Q4 Estimates With $1.11 EPS
Feb 17 2026, 23:33
Mercury General Crushes Q4 Forecasts With $3.66 EPS
Feb 17 2026, 23:32
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Edgen Stock·Feb 04 2026, 22:35Edgen Stock·Feb 04 2026, 22:35
Edgen Stock·Feb 04 2026, 22:35